Electronic prescribing for controlled substances, particularly opioids, is being adopted as a powerful tool in the fight against the national opioid epidemic. Imprivata and DigiCert have partnered to offer a streamlined identity proofing process called Imprivata Confirm ID, which facilitates compliance with electronic prescription regulations. This system enhances convenience and security for verified healthcare practitioners while reducing the opportunities for fraud or abuse. Thirteen US states have already passed laws requiring electronic prescribing, and it will become mandatory for Medicare Part D by 2021.
Vans seized, ‘unsafe’ Uber suspended and drivers quizzed during West Midlands Police sting
In an operation to reduce motoring offences, police officers and driving agencies pulled over and checked vehicles in the Black Country at a quiet industrial
